Exploring the Immunogenicity of Rv2201-519: A T-Cell Epitope-Based Antigen Derived from Mycobacterium tuberculosis AsnB with Implications for Tuberculosis Infection Detection and Vaccine Development

By
Jamie Kang
-
0
27
Investigators constructed a T-cell epitope-rich tripeptide-splicing fragment of Rv2201 from the Mycobacterium tuberculosis genome, ultimately yielding the recombinant protein Rv2201-519 in Escherichia coli BL21.
[International Immunopharmacology]
Abstract